Bausch & Lomb Invests in AcuFocus
ROCHESTER, N.Y., Jan. 15, 2007 -- Bausch & Lomb announced today it has made an equity investment in and secured an exclusive option to purchase AcuFocus Inc., an Irvine, Calif., company that is developing corneal inlay technology for the treatment of presbyopia. The announcement was made at Hawaiian Eye 2007, a meeting of ophthalmic surgeons being held this week in Kauai, Hawaii; it is sponsored by Alcon Laboratories Inc., Allergan, Bausch & Lomb, EagleVision, Genentech, Pfizer Ophthalmics and Refractec Inc.
The...